Toward a world without a need to fight against breast cancer
Lily MedTech Inc. is a spin-off company from the University of Tokyo.
We are developing a medical imaging device for breast cancer and aim to change the world through innovative technology.
Lily MedTech’s Ring Echo is an unprecedented imaging device for detecting breast cancer early, using a ring-type ultrasonic transducer. In cooperation with academic and medical institutions including the University of Tokyo, we are developing this technology with the aim to overcome common issues with current breast cancer diagnostic equipment.
1 out of 11 women will develop breast cancer in her lifetime.
Among women in their 40s, 50s, and 60s who are still active, there is a particularly high morbidity rate. For breast cancer, with early detection and treatment the chances of survival and recovery are very high. However, the domestic medical checkup rate, in Japan remains lower than that of other countries. Moreover, more than half of breast cancer patients in Japan detected it through self examination.
Lily MedTech was established in May 2016 with the aim of developing a new ultrasound imaging system for breast cancer based on research results at the University of Tokyo. Our development is driven by our desire to contribute, to ensuring that women of all ages can remain an active part of society and enjoy the great opportunities in life. Our mission is to protect the lives of women and to bring about a world where breast cancer does not deprive women of the life, choices, or chances they had before being diagnosed.